Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Medpace

IBD Stock Of The Day Medpace Shocked Investors — Now It's Eyeing Multiple Entries

Medpace is the IBD Stock Of The Day. Months after a bullish 2023 call sent MEDP stock soaring, shares are eyeing a buy point.

Investors Business Daily

Dow Jones Futures Rise: 5 Stocks Near Buy Points In Market Rally; Tesla FSD Beta Expands Widely

Dow Jones Futures Rise: 5 Stocks Near Buy Points In Market Rally; Tesla FSD Beta Expands Widely

The S&P 500 still faces its 200-day line with key economic data looming. Tesla FSD Beta gets a wide release after TSLA stock jumped from bear market lows.

Investors Business Daily

IBD 50 Stock Testing Buy Point After 38% One-Day Jump

IBD 50 Stock Testing Buy Point After 38% One-Day Jump

After a huge gap-up on earnings last month, Medpace is researching a return to a prior buy point.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Stock Market Rally Resilient As Apple Bucks Megacap Meltdown: Weekly Review

The market rally was volatile but ultimately rallied broadly. Amazon, Meta, Google and Microsoft sold off on earnings, as Apple jumped on results.

Investors Business Daily

IBD 50 Stocks To Buy And Watch: Medpace Breaks Out After 'Almost Unbelievable' Quarter

Medpace is one of the top stocks to buy and watch as it breaks out past its buy point after reporting "almost unbelievable" results.

Investors Business Daily

Medpace Stock, Grainger, Mosaic, Skyline Among 22 New Stocks On IBD Watchlists Today

Keeping your watchlist up to date is key to making money in the stock market. IBD helps you do that by regularly updating stock screens like the IBD 50, IBD Sector Leaders, IBD Big Cap 20 and IPO Leaders. In the tables below, you can see which stocks have just…

Investors Business Daily

Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies

Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Medpace Posts Better Than Expected Q1 Earnings, Lifts FYY22 Profit Outlook

Medpace Posts Better Than Expected Q1 Earnings, Lifts FYY22 Profit Outlook

Medpace Holdings Inc's (NASDAQ:MEDP) Q1 revenue increased 27.3% Y/Y to $330.9 million, beating the consensus of $327.09 million. On a constant currency organic basis, revenue increased 28.1%. As of March 31, 2022, the Backlog grew 28% to $2.1 billion. Net new business awards were $423 million, representing a net book-to-bill ratio of…

Medpace Reports Mixed Q4 Earnings, Issues FY22 Guidance Ahead Of Estimates

Medpace Reports Mixed Q4 Earnings, Issues FY22 Guidance Ahead Of Estimates

Medpace Holdings Inc's (NASDAQ: MEDP)

Organisations

US Federal Reserve

Intel Corporation

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

249,789 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play